Ironwood Pharmaceuticals Inc
NASDAQ:IRWD
Income Statement
Earnings Waterfall
Ironwood Pharmaceuticals Inc
Revenue
|
442.7m
USD
|
Operating Expenses
|
-274.4m
USD
|
Operating Income
|
168.3m
USD
|
Other Expenses
|
-1.2B
USD
|
Net Income
|
-1B
USD
|
Income Statement
Ironwood Pharmaceuticals Inc
Dec-2013 | Mar-2014 | Jun-2014 | Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||||||||||||||||||||||||||||||
Revenue |
23
N/A
|
34
+49%
|
31
-8%
|
43
+38%
|
76
+76%
|
91
+19%
|
112
+23%
|
134
+20%
|
150
+11%
|
187
+25%
|
213
+14%
|
240
+12%
|
274
+14%
|
260
-5%
|
271
+4%
|
292
+8%
|
298
+2%
|
315
+6%
|
331
+5%
|
310
-6%
|
347
+12%
|
346
0%
|
367
+6%
|
433
+18%
|
428
-1%
|
440
+3%
|
427
-3%
|
399
-6%
|
390
-2%
|
398
+2%
|
413
+4%
|
413
+0%
|
414
+0%
|
422
+2%
|
416
-2%
|
421
+1%
|
411
-2%
|
417
+2%
|
427
+2%
|
432
+1%
|
443
+2%
|
|
Gross Profit | ||||||||||||||||||||||||||||||||||||||||||
Cost of Revenue |
(7)
|
(8)
|
(15)
|
(13)
|
(26)
|
(24)
|
(21)
|
(21)
|
0
|
(8)
|
0
|
0
|
(2)
|
(2)
|
(6)
|
(12)
|
(19)
|
(21)
|
(22)
|
(20)
|
(33)
|
(31)
|
(38)
|
(34)
|
(24)
|
(25)
|
(14)
|
(13)
|
(3)
|
(1)
|
(1)
|
(1)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Gross Profit |
16
N/A
|
26
+69%
|
16
-38%
|
30
+85%
|
51
+67%
|
67
+32%
|
90
+35%
|
113
+25%
|
150
+32%
|
179
+19%
|
213
+19%
|
240
+12%
|
272
+13%
|
258
-5%
|
265
+3%
|
280
+6%
|
279
0%
|
294
+5%
|
309
+5%
|
290
-6%
|
314
+8%
|
315
+0%
|
329
+4%
|
399
+21%
|
405
+2%
|
415
+2%
|
413
0%
|
386
-7%
|
386
+0%
|
398
+3%
|
412
+4%
|
412
+0%
|
414
+0%
|
0
N/A
|
0
N/A
|
0
N/A
|
411
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
Operating Income | ||||||||||||||||||||||||||||||||||||||||||
Operating Expenses |
(268)
|
(234)
|
(219)
|
(214)
|
(220)
|
(220)
|
(230)
|
(233)
|
(234)
|
(255)
|
(253)
|
(291)
|
(324)
|
(347)
|
(380)
|
(386)
|
(294)
|
(287)
|
(273)
|
(222)
|
(300)
|
(298)
|
(282)
|
(301)
|
(288)
|
(295)
|
(255)
|
(244)
|
(230)
|
(209)
|
(191)
|
(173)
|
(182)
|
(178)
|
(180)
|
(182)
|
(160)
|
(165)
|
(210)
|
(239)
|
(274)
|
|
Selling, General & Administrative |
(165)
|
(137)
|
(124)
|
(116)
|
(118)
|
(119)
|
(122)
|
(124)
|
(125)
|
(131)
|
(135)
|
(150)
|
(173)
|
(193)
|
(214)
|
(230)
|
(231)
|
(235)
|
(237)
|
(227)
|
(222)
|
(212)
|
(196)
|
(184)
|
(173)
|
(160)
|
(151)
|
(145)
|
(142)
|
(133)
|
(126)
|
(118)
|
(111)
|
(112)
|
(115)
|
(116)
|
(116)
|
(118)
|
(141)
|
(148)
|
(158)
|
|
Research & Development |
(102)
|
(97)
|
(95)
|
(97)
|
(102)
|
(101)
|
(108)
|
(109)
|
(109)
|
(114)
|
(117)
|
(129)
|
(140)
|
(141)
|
(147)
|
(147)
|
(88)
|
(95)
|
(81)
|
(73)
|
(101)
|
(113)
|
(118)
|
(117)
|
(115)
|
(111)
|
(104)
|
(98)
|
(88)
|
(76)
|
(66)
|
(55)
|
(70)
|
(66)
|
(65)
|
(66)
|
(44)
|
(46)
|
(69)
|
(91)
|
(116)
|
|
Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
(4)
|
(1)
|
(5)
|
(4)
|
(3)
|
(6)
|
(9)
|
(12)
|
(12)
|
(8)
|
0
|
(1)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(10)
|
0
|
(9)
|
(10)
|
(8)
|
(15)
|
(6)
|
31
|
52
|
57
|
90
|
31
|
27
|
34
|
0
|
0
|
(24)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Operating Income |
(252)
N/A
|
(208)
+18%
|
(203)
+2%
|
(183)
+10%
|
(169)
+7%
|
(153)
+10%
|
(140)
+9%
|
(120)
+14%
|
(85)
+30%
|
(76)
+10%
|
(40)
+48%
|
(51)
-29%
|
(52)
0%
|
(89)
-73%
|
(115)
-29%
|
(106)
+8%
|
(15)
+86%
|
8
N/A
|
37
+384%
|
68
+86%
|
14
-80%
|
17
+22%
|
47
+180%
|
97
+105%
|
116
+19%
|
119
+3%
|
158
+32%
|
142
-10%
|
157
+10%
|
189
+21%
|
221
+17%
|
239
+8%
|
232
-3%
|
245
+5%
|
235
-4%
|
239
+1%
|
250
+5%
|
253
+1%
|
217
-14%
|
193
-11%
|
168
-13%
|
|
Pre-Tax Income | ||||||||||||||||||||||||||||||||||||||||||
Interest Income Expense |
(21)
|
(21)
|
(21)
|
(21)
|
(21)
|
(21)
|
(22)
|
(38)
|
(41)
|
(47)
|
(47)
|
(31)
|
(30)
|
(29)
|
(26)
|
(34)
|
(38)
|
(34)
|
(40)
|
(33)
|
(44)
|
(41)
|
(41)
|
(50)
|
(31)
|
(36)
|
(34)
|
(29)
|
(34)
|
(29)
|
(32)
|
(28)
|
(32)
|
(28)
|
(19)
|
(12)
|
2
|
9
|
18
|
8
|
(3)
|
|
Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(10)
|
(18)
|
0
|
(10)
|
0
|
(0)
|
(2)
|
(3)
|
(3)
|
(2)
|
(3)
|
(5)
|
(164)
|
(165)
|
(165)
|
(159)
|
(28)
|
(27)
|
0
|
(27)
|
(1)
|
(14)
|
(14)
|
(14)
|
(12)
|
0
|
0
|
0
|
(0)
|
0
|
0
|
(1 103)
|
(1 108)
|
(1 114)
|
|
Total Other Income |
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Pre-Tax Income |
(273)
N/A
|
(229)
+16%
|
(224)
+2%
|
(204)
+9%
|
(190)
+7%
|
(173)
+9%
|
(161)
+7%
|
(166)
-3%
|
(143)
+14%
|
(123)
+14%
|
(96)
+21%
|
(82)
+15%
|
(82)
+1%
|
(121)
-48%
|
(143)
-19%
|
(143)
+1%
|
(55)
+61%
|
(29)
+47%
|
(9)
+69%
|
(128)
-1 343%
|
(194)
-51%
|
(189)
+2%
|
(153)
+19%
|
20
N/A
|
59
+202%
|
84
+43%
|
97
+15%
|
112
+16%
|
109
-3%
|
146
+34%
|
175
+20%
|
199
+14%
|
201
+1%
|
217
+8%
|
216
0%
|
226
+5%
|
252
+11%
|
262
+4%
|
(868)
N/A
|
(906)
-4%
|
(948)
-5%
|
|
Net Income | ||||||||||||||||||||||||||||||||||||||||||
Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
(3)
|
(3)
|
334
|
331
|
328
|
311
|
(43)
|
(59)
|
(77)
|
(80)
|
(76)
|
(75)
|
(83)
|
|
Income from Continuing Operations |
(273)
|
(229)
|
(224)
|
(204)
|
(190)
|
(173)
|
(161)
|
(166)
|
(143)
|
(123)
|
(96)
|
(82)
|
(82)
|
(121)
|
(143)
|
(143)
|
(55)
|
(29)
|
(9)
|
(128)
|
(194)
|
(189)
|
(153)
|
20
|
59
|
84
|
97
|
111
|
106
|
143
|
509
|
530
|
528
|
527
|
173
|
168
|
175
|
182
|
(945)
|
(981)
|
(1 032)
|
|
Income to Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
27
|
29
|
29
|
|
Net Income (Common) |
(273)
N/A
|
(229)
+16%
|
(224)
+2%
|
(204)
+9%
|
(190)
+7%
|
(173)
+9%
|
(161)
+7%
|
(166)
-3%
|
(143)
+14%
|
(123)
+14%
|
(96)
+21%
|
(82)
+15%
|
(82)
+1%
|
(121)
-48%
|
(143)
-19%
|
(143)
+1%
|
(117)
+18%
|
(108)
+8%
|
(113)
-5%
|
(255)
-126%
|
(282)
-11%
|
(299)
-6%
|
(237)
+21%
|
(42)
+82%
|
22
N/A
|
84
+291%
|
97
+15%
|
111
+14%
|
106
-4%
|
143
+34%
|
509
+257%
|
530
+4%
|
528
0%
|
527
0%
|
173
-67%
|
168
-3%
|
175
+4%
|
182
+4%
|
(917)
N/A
|
(952)
-4%
|
(1 002)
-5%
|
|
EPS (Diluted) |
-2.25
N/A
|
-1.76
+22%
|
-1.61
+9%
|
-1.46
+9%
|
-1.39
+5%
|
-1.22
+12%
|
-1.15
+6%
|
-1.18
-3%
|
-1
+15%
|
-0.86
+14%
|
-0.67
+22%
|
-0.57
+15%
|
-0.56
+2%
|
-0.83
-48%
|
-0.98
-18%
|
-0.97
+1%
|
-0.78
+20%
|
-0.7
+10%
|
-0.72
-3%
|
-1.66
-131%
|
-1.85
-11%
|
-1.92
-4%
|
-1.52
+21%
|
-0.26
+83%
|
0.13
N/A
|
0.54
+315%
|
0.62
+15%
|
0.7
+13%
|
0.66
-6%
|
0.89
+35%
|
3.12
+251%
|
3.2
+3%
|
3.21
+0%
|
2.78
-13%
|
0.93
-67%
|
0.9
-3%
|
0.93
+3%
|
0.97
+4%
|
-5.9
N/A
|
-5.09
+14%
|
-6.45
-27%
|